Besides, M1-type TAMs can exert a direct killing effect on tumor cells once activated by IFN-γ or mediate adaptive immunity by recruiting and activating CD8+ T cells and NK cells after presenting tumor antigens and producing chemokines and cytokines (50). The gene discussed is CD8A; the disease is neoplasm.